Leishmania major lipophosphoglycan: Discrepancy in toll-like receptor signaling

Experimental Parasitology

Volumn 124, Issue 2, 2010, Pages 214-218

  Kavoosi, Gholamreza ^a   Ardestani, Sussan K ^b   Kariminia, Amina ^c   Alimohammadian, Mohammad Hossein ^c  

^a SHIRAZ UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Capillary electrophoresis; Immunoblotting; Leishmania; Lipophosphoglycan; Nitric oxide; Toll like receptor 2

Indexed keywords

LIPOPHOSPHOGLYCAN; NITRIC OXIDE; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CAPILLARY ELECTROPHORESIS; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; IMMUNOBLOTTING; LEISHMANIA MAJOR; MACROPHAGE; MOLECULAR SIZE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ANIMALS; CELL LINE; ELECTROPHORESIS, CAPILLARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSPHINGOLIPIDS; IMMUNOBLOTTING; LEISHMANIA MAJOR; MACROPHAGES; MICE; NITRIC OXIDE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

LEISHMANIA MAJOR;

EID: 73449106411     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.09.017     Document Type: Article

References (36)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
2. Amato V.S., Tuon F.F., Bacha H.A., Neto V.A., and Nicodemo A.C. Mucosal leishmaniasis: current scenario and prospects for treatment. Acta Tropica 105 (2008) 1-9
3. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatases. Methods in Enzymology 8 (1996) 115-118
4. Barron T.L., and Turco S.J. Quantitation of Leishmania lipophosphoglycan repeat units by capillary electrophoresis. Biophysical Biochemical Acta 1760 (2006) 710-714
5. Brodsky I., and Medzhitov R. Two modes of ligand recognition by TLRs. Cell 130 (2007) 979-981
6. Buwitt-Beckmann1 U., Heine H., Wiesmuller K.H., Jung G., Brock R., and Ulmer A.J. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS Journal 272 (2005) 6354-6364
7. Charmoy M., Megnekou R., Allenbach C., Zweifel C., Perez C., Monnat K., Breton M., Ronet C., Launois P., and Tacchini-Cottier F. Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection. Journal of Leukocyte Biology 82 (2007) 288-299
8. De Veer M.J., Curtis J.M., Baldwin T.M., Di Donato J.A., Sexton A., Mc Conville M.J., Handman E., and Schofield L. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. European Journal of Immunology 33 (2003) 2822-2831
9. Dermine J.F., Scianimanico S., Prive C., Descoteaux A., and Desjardins M. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis. Cellular Microbiology 2 (2000) 115-126
10. Descoteaux A., and Turco S.J. Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage function. Microbes and Infection 4 (2002) 975-986
11. Flandin J.F., Chano F., and Descoteaux A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. European Journal of Immunology 36 (2006) 411-420
12. Handman E., and Bullen V.R.D. Interaction of Leishmania with host macrophage. Trends in Parasitology 18 (2002) 332-334
13. Ilg T., Stierhof Y.D., Craik D., Simpson R., Handman E., and Bacic A. Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. Journal of Biological Chemistry 271 (1996) 21583-21596
14. Ilg T., Stierhof Y.D., Wiese M., Mc Conville M.J., and Overath P. Characterization of phosphoglycan-containing secretory products of Leishmania. Parasitology 108 (1994) S63-S71
15. Khan S., Weterings J.J., Britten C.M., De Jong A.R., Graafland D., Melief C.J., Van Der Burg S.H., van der Marel G., Overkleeft H.S., Filippov D.V., and Ossendorp F. Chirality of TLR-2 ligand Pam (3)CysSK(4) in fully synthetic peptide conjugates critically influences the induction of specific CD8(+) T-cells. Molecular Immunology 46 (2009) 1084-1091
16. Mahoney A.B., Sacks D.L., Saraiva E., Modi G., and Turco S.J. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions. Biochemistry 38 (1999) 9813-9823
17. Mc Conville M.J., Turco S.J., Ferguson M.A., and Sacks D.L. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO Journal 11 (1992) 3593-3600
18. Mc Conville M.J., Bacic A., Mitchell G.F., and Handman E. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphatidylinositol lipid anchor. Proceedings of the National Academy of Sciences of the USA 84 (1987) 8941-8945
19. Miranda M.K., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62-71
20. Naderer T., Vince J.E., and Mc Conville M.J. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Current Molecular Medicine 4 (2004) 649-665
21. Pinheiro R.O., Pinto E.F., Guedes H.L., Filho O.A., De Mattos K.A., Saraiva E.M., De Mendonça S.C., and Rossi-Bergmann B. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan. Vaccine 25 (2007) 2716-2722
22. Rao P., and Pattabiraman T.N. Re-evolution of the phenol-sulfuric acid reaction for the estimation of hexoses and pentoses. Analytical Biochemistry 181 (1989) 18-22
23. Sacks D.L. Metacyclogenesis in Leishmania amastigotes. Experimental Parasitology 69 (1989) 100-103
24. Sacks D.L., Brodin T.N., and Turco S.J. Developmental modification of the lipophosphoglycan from Leishmania major promastogotes during metacyclogenesis. Molecular and Biochemical Parasitology 42 (1990) 225-234
25. Sacks D.L., Hieny S., and Sher A. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. Journal of Immunology 135 (1985) 564-569
26. Sacks D., and Kamhawi S. Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis. Annual Review of Microbiology 5 (2001) 453-483
27. Sacks D.L., Pimenta P.F.P., Mc Conville M.J., Schneider P., and Turco S.J. Tage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. Journal of Experimental Medicine 181 (1995) 685-697
28. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annual Review Immunology 1 (2002) 335-376
29. Thomas J.R., Mc Conville M.J., Thomas-Oates J.E., Homans S.W., Ferguson .A.J., Gorin P.A.J., Greis K.D., and Turco S.J. Refined structure of the lipophosphoglycan of Leishmania donovani. The Journal of Biological Chemistry 267 (1992) 6829-6833
30. Tonui W.K., Mbati P.A., Anjili C.O., Orago A.S., Turco S.J., Githure J.I., and Koech K. Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis. East African Medical Journal 78 (2001) 84-89
31. Turco S.J., Wilkerson M.A., and Clawsons D.R. Expression of an unusual acidic glycoconjugate in Leishmania donovanis. Journal of Biological Chemistry 259 (1984) 3883-3889
32. Van Der Kleij D., Latz E., Brouwers J.F., Kruize Y.C., Schmitz M., Kurt-Jones E.A., Espevik T., De Jong E.C., Kapsenberg M.L., Golenbock D.T., Tielens A.G., and Yazdanbakhsh M. A novel host-parasite lipid cross-talk. Schistosomal lysophosphatidylserine activates Toll-like receptor 2 and affects immune polarization. Journal of Biological Chemistry 277 (2002) 48122-48129
33. Villasenor-Cardoso M.I., Salaiza N., Delgado J., Gutierrez-Kobeh L., Perez-Torres A., and Becker I. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host. Parasite Immunology 30 (2008) 425-434
34. Wang B., Henao-Tamayo M., Harton M., Ordway D., Shanley C., Basaraba R.J., and Orme I.M. A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis. Clinical and Vaccine Immunology 14 (2007) 902-906
35. Zambrano-Villa S.D., Rosales-Borjas J.C., and Ortiz-Ortiz L. How protozoan parasites evade the immune response. Trends in Parasitology 18 (2002) 272-278
36. Zhang X., Chentoufi A.A., Dasgupta G., Nesburn A.B., Wu M., Zhu X., Carpenter D., Wechsler S.L., You S., and Ben Mohamed L. A genital tract peptide epitope vaccine targeting TLR 2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunology 2 (2009) 129-143